These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 30133549)

  • 21. A non-invasively determined surrogate of cardiac power ('circulatory power') at peak exercise is a powerful prognostic factor in chronic heart failure.
    Cohen-Solal A; Tabet JY; Logeart D; Bourgoin P; Tokmakova M; Dahan M
    Eur Heart J; 2002 May; 23(10):806-14. PubMed ID: 12009721
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Left atrial and left ventricular diastolic function in chronic Chagas disease.
    Nascimento CA; Gomes VA; Silva SK; Santos CR; Chambela MC; Madeira FS; Holanda MT; Brasil PE; Sousa AS; Xavier SS; Hasslocher-Moreno AM; Cunha AB; Saraiva RM
    J Am Soc Echocardiogr; 2013 Dec; 26(12):1424-33. PubMed ID: 24055123
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Predictors of all-cause mortality in chronic Chagas' heart disease in the current era of heart failure therapy.
    Theodoropoulos TA; Bestetti RB; Otaviano AP; Cordeiro JA; Rodrigues VC; Silva AC
    Int J Cardiol; 2008 Aug; 128(1):22-9. PubMed ID: 18258318
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Additive prognostic value of subjective assessment with respect to clinical cardiological data in patients with chronic heart failure.
    Majani G; Pierobon A; Pinna GD; Giardini A; Maestri R; La Rovere MT
    Eur J Cardiovasc Prev Rehabil; 2011 Dec; 18(6):836-42. PubMed ID: 21450593
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cardiopulmonary Exercise Testing and Prognosis in Hypertrophic Cardiomyopathy.
    Coats CJ; Rantell K; Bartnik A; Patel A; Mist B; McKenna WJ; Elliott PM
    Circ Heart Fail; 2015 Nov; 8(6):1022-31. PubMed ID: 26374874
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Global Longitudinal Strain Is a Superior Predictor of All-Cause Mortality in Heart Failure With Reduced Ejection Fraction.
    Sengeløv M; Jørgensen PG; Jensen JS; Bruun NE; Olsen FJ; Fritz-Hansen T; Nochioka K; Biering-Sørensen T
    JACC Cardiovasc Imaging; 2015 Dec; 8(12):1351-1359. PubMed ID: 26577264
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Why do patients with chagasic cardiomyopathy have worse outcomes than those with non-chagasic cardiomyopathy?
    Silva CP; Del Carlo CH; Oliveira Junior MT; Scipioni A; Strunz-Cassaro C; Ramirez JA; Pereira Barretto AC
    Arq Bras Cardiol; 2008 Dec; 91(6):358-62. PubMed ID: 19142362
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prognostic value of 6-minute walk test in stable outpatients with heart failure.
    Arslan S; Erol MK; Gundogdu F; Sevimli S; Aksakal E; Senocak H; Alp N
    Tex Heart Inst J; 2007; 34(2):166-9. PubMed ID: 17622362
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of acute aerobic exercise on serum BDNF levels in patients with Chagas heart disease.
    Costa HS; Lima MM; Silva MG; Alencar MC; Nunes MC; Camargos ER; Martinelli PM; Rocha MO
    Int J Cardiol; 2014 Jul; 174(3):828-30. PubMed ID: 24794957
    [No Abstract]   [Full Text] [Related]  

  • 30. Additive prognostic value of cardiopulmonary exercise testing in elderly patients with heart failure.
    Scardovi AB; De Maria R; Celestini A; Perna S; Coletta C; Feola M; Aspromonte N; Rosso GL; Carunchio A; Ferraironi A; Pimpinella A; Ricci R
    Clin Sci (Lond); 2009 Mar; 116(5):415-22. PubMed ID: 18699772
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Value of clinical, electrocardiographic, echocardiographic and neurohumoral parameters in non-ischaemic dilated cardiomyopathy.
    Tigen K; Karaahmet T; Tanalp AC; Gurel E; Cevik C; Mutlu B; Basaran Y
    Acta Cardiol; 2008 Apr; 63(2):207-12. PubMed ID: 18468202
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Ambulatory blood pressure monitoring, 2D-echo and clinical variables relating to cardiac events in ischaemic cardiomyopathy following cardioverter-defibrillator implantation.
    Antonini L; Pasceri V; Mollica C; Ficili S; Poti G; Aquilani S; Santini M; La Rocca S
    J Cardiovasc Med (Hagerstown); 2011 May; 12(5):334-9. PubMed ID: 21487343
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The role of exercise ventilation in clinical evaluation and risk stratification in patients with chronic heart failure.
    Jankowska EA; Pietruk-Kowalczyk J; Zymliński R; Witkowski T; Ponikowska B; Sebzda T; Rzeczuch K; Borodulin-Nadzieja L; Hańczycowa H; Banasiak W; Ponikowski P
    Kardiol Pol; 2003 Aug; 59(8):115-27; commentary 126-7. PubMed ID: 14560326
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prognostic value of a new cardiopulmonary exercise testing parameter in chronic heart failure: oxygen uptake efficiency at peak exercise - comparison with oxygen uptake efficiency slope.
    Toste A; Soares R; Feliciano J; Andreozzi V; Silva S; Abreu A; Ramos R; Santos N; Ferreira L; Ferreira RC
    Rev Port Cardiol; 2011 Oct; 30(10):781-7. PubMed ID: 22118129
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The independent prognostic value of contractile and coronary flow reserve determined by dipyridamole stress echocardiography in patients with idiopathic dilated cardiomyopathy.
    Rigo F; Gherardi S; Galderisi M; Sicari R; Picano E
    Am J Cardiol; 2007 Apr; 99(8):1154-8. PubMed ID: 17437747
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The prevalence and prognostic significance of right ventricular systolic dysfunction in nonischemic dilated cardiomyopathy.
    Gulati A; Ismail TF; Jabbour A; Alpendurada F; Guha K; Ismail NA; Raza S; Khwaja J; Brown TD; Morarji K; Liodakis E; Roughton M; Wage R; Pakrashi TC; Sharma R; Carpenter JP; Cook SA; Cowie MR; Assomull RG; Pennell DJ; Prasad SK
    Circulation; 2013 Oct; 128(15):1623-33. PubMed ID: 23965488
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Improving survival rates of patients with idiopathic dilated cardiomyopathy in Tuscany over 3 decades: impact of evidence-based management.
    Castelli G; Fornaro A; Ciaccheri M; Dolara A; Troiani V; Tomberli B; Olivotto I; Gensini GF
    Circ Heart Fail; 2013 Sep; 6(5):913-21. PubMed ID: 23888044
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Longitudinal strain combined with delayed-enhancement magnetic resonance improves risk stratification in patients with dilated cardiomyopathy.
    Chimura M; Onishi T; Tsukishiro Y; Sawada T; Kiuchi K; Shimane A; Okajima K; Yamada S; Taniguchi Y; Yasaka Y; Kawai H
    Heart; 2017 May; 103(9):679-686. PubMed ID: 27799316
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prognostic utility of anemia and pro-B-type natriuretic peptide in patients with nonischemic dilated cardiomyopathy and normal renal function.
    Tigen K; Karaahmet T; Cevik C; Gurel E; Mutlu B; Basaran Y
    Am J Med Sci; 2009 Feb; 337(2):109-15. PubMed ID: 19214026
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Maximal functional capacity, ejection fraction, and functional class in Chagas cardiomyopathy. Are these indices related?].
    Mady C; Salemi VM; Ianni BM; Ramires FJ; Arteaga E
    Arq Bras Cardiol; 2005 Feb; 84(2):152-5. PubMed ID: 15761639
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.